Published in:
01-04-2008 | Poster presentation
Impact of treatment with pravastatin on delayed ischemic disease and mortality after aneurysmal subarachnoid hemorrhage
Authors:
U Jaschinski, K Scherer, M Lichtwarck, H Forst
Published in:
Critical Care
|
Special Issue 2/2008
Login to get access
Excerpt
Statins have neuroprotective properties including improved vasomotor reactivity, reduced platelet activation and anti-inflammatory effects [
1]. A prospective observational controlled study was conducted to evaluate the impact of pravastatin on the development of delayed ischemic disease (DID) and ICU mortality after aneurysmal subarachnoid hemorrhage (aSAH). …